Decade of GeneCards Symposium
New Search (GeneCards Home)  |  GeneCards Guide  |    User Feedback WIN AN
 iPod!!!
 |  Terms of Use  |  Notice about third-party sites
  This service is provided free to academic non-profit institutions. ALL other users require a Commercial License from XenneX, Inc.
What's New
GeneCards Guide
  Getting Started
  About GeneCards
  Data Sources
  Citing This Resource
  Publications

Mirror sites

Weizmann Institute of
Science

Crown Human Genome
Center

Bioinformatics Unit

Jobs


GeneCards® Hot Genes

The following is a list of "hot" genes: those that have been most frequently requested at the GeneCards home site since Dec 21, 2007 sorted by frequency of access.

  1. SORT1 sortilin 1
  2. EGFR epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
  3. BRCA1 breast cancer 1, early onset
  4. EPHB4 EPH receptor B4
  5. VIM vimentin
  6. TP53 tumor protein p53 (Li-Fraumeni syndrome)
  7. NR4A2 nuclear receptor subfamily 4, group A, member 2
  8. DMD dystrophin (muscular dystrophy, Duchenne and Becker types)
  9. HGF hepatocyte growth factor (hepapoietin A; scatter factor)
  10. INSR insulin receptor
  11. CFTR cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
  12. PCNA proliferating cell nuclear antigen
  13. NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
  14. CREBBP CREB binding protein (Rubinstein-Taybi syndrome)
  15. FBN1 fibrillin 1
  16. EP300 E1A binding protein p300
  17. BRCA2 breast cancer 2, early onset
  18. ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
  19. FGF2 fibroblast growth factor 2 (basic)
  20. AKT1 v-akt murine thymoma viral oncogene homolog 1
  21. ADRB2 adrenergic, beta-2-, receptor, surface
  22. BCL2 B-cell CLL/lymphoma 2
  23. PSAP prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)
  24. HEXB hexosaminidase B (beta polypeptide)
  25. TOP2A topoisomerase (DNA) II alpha 170kDa
  26. BMP4 bone morphogenetic protein 4
  27. PTEN phosphatase and tensin homolog (mutated in multiple advanced cancers 1)
  28. APP amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)
  29. JAK2 Janus kinase 2 (a protein tyrosine kinase)
  30. FYN FYN oncogene related to SRC, FGR, YES
  31. ABL1 v-abl Abelson murine leukemia viral oncogene homolog 1
  32. HEXA hexosaminidase A (alpha polypeptide)
  33. ATM ataxia telangiectasia mutated
  34. MAPK8 mitogen-activated protein kinase 8
  35. PARP1 poly (ADP-ribose) polymerase family, member 1
  36. GJA1 gap junction protein, alpha 1, 43kDa
  37. GAPDH glyceraldehyde-3-phosphate dehydrogenase
  38. APOE apolipoprotein E
  39. SOD1 superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
  40. ERCC1 excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)
  41. VEGFA vascular endothelial growth factor A
  42. AR androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
  43. CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa
  44. RB1 retinoblastoma 1 (including osteosarcoma)
  45. CDH1 cadherin 1, type 1, E-cadherin (epithelial)
  46. HIF1A hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
  47. ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
  48. ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
  49. ACHE acetylcholinesterase (Yt blood group)
  50. MAPK14 mitogen-activated protein kinase 14
  51. GRB2 growth factor receptor-bound protein 2
  52. APC adenomatosis polyposis coli
  53. MTHFR 5,10-methylenetetrahydrofolate reductase (NADPH)
  54. NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
  55. MET met proto-oncogene (hepatocyte growth factor receptor)
  56. TNF tumor necrosis factor (TNF superfamily, member 2)
  57. ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
  58. HFE hemochromatosis
  59. ESR1 estrogen receptor 1
  60. STAT3 signal transducer and activator of transcription 3 (acute-phase response factor)
  61. MAPK1 mitogen-activated protein kinase 1
  62. HBB hemoglobin, beta
  63. BTK Bruton agammaglobulinemia tyrosine kinase
  64. FGFR1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)
  65. ATP7B ATPase, Cu++ transporting, beta polypeptide
  66. PRKAA1 protein kinase, AMP-activated, alpha 1 catalytic subunit
  67. BCL2L1 BCL2-like 1
  68. CCR5 chemokine (C-C motif) receptor 5
  69. PIK3CA phosphoinositide-3-kinase, catalytic, alpha polypeptide
  70. BLM Bloom syndrome
  71. BDNF brain-derived neurotrophic factor
  72. VDR vitamin D (1,25- dihydroxyvitamin D3) receptor
  73. RAC1 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
  74. FMR1 fragile X mental retardation 1
  75. GCK glucokinase (hexokinase 4, maturity onset diabetes of the young 2)
  76. PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
  77. ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
  78. CASP9 caspase 9, apoptosis-related cysteine peptidase
  79. RELA v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian)
  80. MSH2 mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
  81. PPARG peroxisome proliferator-activated receptor gamma
  82. CD4 CD4 molecule
  83. JUN jun oncogene
  84. MYC v-myc myelocytomatosis viral oncogene homolog (avian)
  85. CASP8 caspase 8, apoptosis-related cysteine peptidase
  86. A2M alpha-2-macroglobulin
  87. PSEN1 presenilin 1 (Alzheimer disease 3)
  88. KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
  89. ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
  90. ALDH2 aldehyde dehydrogenase 2 family (mitochondrial)
  91. CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6
  92. MDM2 Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)
  93. IGF1 insulin-like growth factor 1 (somatomedin C)
  94. EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2
  95. IL6 interleukin 6 (interferon, beta 2)
  96. GSN gelsolin (amyloidosis, Finnish type)
  97. MMP2 matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
  98. BAD BCL2-antagonist of cell death
  99. ERBB4 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
  100. LPL lipoprotein lipase
  101. BAX BCL2-associated X protein
  102. NOS1 nitric oxide synthase 1 (neuronal)
  103. NTRK1 neurotrophic tyrosine kinase, receptor, type 1
  104. GSTM1 glutathione S-transferase M1
  105. MAPK3 mitogen-activated protein kinase 3
  106. CDC2 cell division cycle 2, G1 to S and G2 to M
  107. GBA glucosidase, beta; acid (includes glucosylceramidase)
  108. ATP7A ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)
  109. INS insulin
  110. NAT2 N-acetyltransferase 2 (arylamine N-acetyltransferase)
  111. TGFB1 transforming growth factor, beta 1
  112. ITGA2 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
  113. ARSA arylsulfatase A
  114. CDK4 cyclin-dependent kinase 4
  115. IL1B interleukin 1, beta
  116. E2F1 E2F transcription factor 1
  117. ARNT aryl hydrocarbon receptor nuclear translocator
  118. CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1)
  119. BRAF v-raf murine sarcoma viral oncogene homolog B1
  120. ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
  121. TUBB tubulin, beta
  122. WRN Werner syndrome
  123. MAPK9 mitogen-activated protein kinase 9
  124. CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
  125. VWF von Willebrand factor
  126. ESR2 estrogen receptor 2 (ER beta)
  127. ATF4 activating transcription factor 4 (tax-responsive enhancer element B67)
  128. BLNK B-cell linker
  129. PIN1 protein (peptidylprolyl cis/trans isomerase) NIMA-interacting 1
  130. SHC1 SHC (Src homology 2 domain containing) transforming protein 1
  131. CCND1 cyclin D1
  132. NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
  133. NOS2A nitric oxide synthase 2A (inducible, hepatocytes)
  134. CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
  135. ACADM acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain
  136. AOC3 amine oxidase, copper containing 3 (vascular adhesion protein 1)
  137. GSTP1 glutathione S-transferase pi
  138. GSTT1 glutathione S-transferase theta 1
  139. CASP3 caspase 3, apoptosis-related cysteine peptidase
  140. BIRC5 baculoviral IAP repeat-containing 5 (survivin)
  141. PDGFRA platelet-derived growth factor receptor, alpha polypeptide
  142. G6PD glucose-6-phosphate dehydrogenase
  143. SOX9 SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)
  144. HRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog
  145. CDK5 cyclin-dependent kinase 5
  146. PRNP prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)
  147. KDR kinase insert domain receptor (a type III receptor tyrosine kinase)
  148. STAT1 signal transducer and activator of transcription 1, 91kDa
  149. CHEK2 CHK2 checkpoint homolog (S. pombe)
  150. CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
  151. HNF4A hepatocyte nuclear factor 4, alpha
  152. CCL2 chemokine (C-C motif) ligand 2
  153. HMOX1 heme oxygenase (decycling) 1
  154. MAP2K1 mitogen-activated protein kinase kinase 1
  155. KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
  156. SREBF1 sterol regulatory element binding transcription factor 1
  157. CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2
  158. TUBA8 tubulin, alpha 8
  159. FAS Fas (TNF receptor superfamily, member 6)
  160. ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide
  161. PAX6 paired box 6
  162. ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
  163. MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor)
  164. RET ret proto-oncogene
  165. PLAU plasminogen activator, urokinase
  166. ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
  167. SGK serum/glucocorticoid regulated kinase
  168. ACTA1 actin, alpha 1, skeletal muscle
  169. FGFR2 fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)
  170. NQO1 NAD(P)H dehydrogenase, quinone 1
  171. JAK3 Janus kinase 3 (a protein tyrosine kinase, leukocyte)
  172. NOTCH1 Notch homolog 1, translocation-associated (Drosophila)
  173. ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
  174. ACTB actin, beta
  175. PTGDS prostaglandin D2 synthase 21kDa (brain)
  176. MECP2 methyl CpG binding protein 2 (Rett syndrome)
  177. LDLR low density lipoprotein receptor (familial hypercholesterolemia)
  178. HLA-B major histocompatibility complex, class I, B
  179. COL1A1 collagen, type I, alpha 1
  180. SMAD4 SMAD family member 4
  181. RAF1 v-raf-1 murine leukemia viral oncogene homolog 1
  182. FLNB filamin B, beta (actin binding protein 278)
  183. EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3
  184. TPI1 triosephosphate isomerase 1
  185. RHOA ras homolog gene family, member A
  186. LCK lymphocyte-specific protein tyrosine kinase
  187. MGMT O-6-methylguanine-DNA methyltransferase
  188. ACTN4 actinin, alpha 4
  189. DRD2 dopamine receptor D2
  190. GHR growth hormone receptor
  191. FRAP1 FK506 binding protein 12-rapamycin associated protein 1
  192. H19 H19, imprinted maternally expressed untranslated mRNA
  193. FASLG Fas ligand (TNF superfamily, member 6)
  194. FLT1 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
  195. EGF epidermal growth factor (beta-urogastrone)
  196. RUNX1 runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)
  197. CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9
  198. NF1 neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)
  199. TERT telomerase reverse transcriptase
  200. ITGAM integrin, alpha M (complement component 3 receptor 3 subunit)
  201. SOD2 superoxide dismutase 2, mitochondrial
  202. VCP valosin-containing protein
  203. PRKG1 protein kinase, cGMP-dependent, type I
  204. CASR calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism)
  205. MLL myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
  206. CYP2E1 cytochrome P450, family 2, subfamily E, polypeptide 1
  207. HPRT1 hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome)
  208. PRKCG protein kinase C, gamma
  209. HTT huntingtin
  210. TGFB3 transforming growth factor, beta 3
  211. PBX1 pre-B-cell leukemia homeobox 1
  212. IL8 interleukin 8
  213. RARA retinoic acid receptor, alpha
  214. SP1 Sp1 transcription factor
  215. AKT2 v-akt murine thymoma viral oncogene homolog 2
  216. LEPR leptin receptor
  217. NGFR nerve growth factor receptor (TNFR superfamily, member 16)
  218. ERCC2 excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)
  219. NTRK2 neurotrophic tyrosine kinase, receptor, type 2
  220. CP ceruloplasmin (ferroxidase)
  221. MPO myeloperoxidase
  222. CXCR4 chemokine (C-X-C motif) receptor 4
  223. THBS1 thrombospondin 1
  224. SRC v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
  225. CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1
  226. PML promyelocytic leukemia
  227. WNT2 wingless-type MMTV integration site family member 2
  228. CDK2 cyclin-dependent kinase 2
  229. ABCD1 ATP-binding cassette, sub-family D (ALD), member 1
  230. FN1 fibronectin 1
  231. NOS3 nitric oxide synthase 3 (endothelial cell)
  232. ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
  233. MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
  234. MYL3 myosin, light chain 3, alkali; ventricular, skeletal, slow
  235. CDC42 cell division cycle 42 (GTP binding protein, 25kDa)
  236. NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin)
  237. A1BG alpha-1-B glycoprotein
  238. IL2 interleukin 2
  239. LIPA lipase A, lysosomal acid, cholesterol esterase (Wolman disease)
  240. PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)
  241. FGFR3 fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)
  242. ADRB1 adrenergic, beta-1-, receptor
  243. CBL Cas-Br-M (murine) ecotropic retroviral transforming sequence
  244. ASS1 argininosuccinate synthetase 1
  245. WNT1 wingless-type MMTV integration site family, member 1
  246. COMT catechol-O-methyltransferase
  247. ZAP70 zeta-chain (TCR) associated protein kinase 70kDa
  248. TTR transthyretin (prealbumin, amyloidosis type I)
  249. FUK fucokinase
  250. ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
  251. IGF1R insulin-like growth factor 1 receptor
  252. LEP leptin (obesity homolog, mouse)
  253. RYR1 ryanodine receptor 1 (skeletal)
  254. MLH1 mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
  255. CHUK conserved helix-loop-helix ubiquitous kinase
  256. ABAT 4-aminobutyrate aminotransferase
  257. DMPK dystrophia myotonica-protein kinase
  258. SYK spleen tyrosine kinase
  259. ALK anaplastic lymphoma kinase (Ki-1)
  260. CYCS cytochrome c, somatic
  261. CD44 CD44 molecule (Indian blood group)
  262. GNAS GNAS complex locus
  263. ADIPOQ adiponectin, C1Q and collagen domain containing
  264. FOS v-fos FBJ murine osteosarcoma viral oncogene homolog
  265. WT1 Wilms tumor 1
  266. B2M beta-2-microglobulin
  267. LMNA lamin A/C
  268. CSF3 colony stimulating factor 3 (granulocyte)
  269. GLA galactosidase, alpha
  270. SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
  271. CHEK1 CHK1 checkpoint homolog (S. pombe)
  272. CTSD cathepsin D
  273. SMAD3 SMAD family member 3
  274. WNT5A wingless-type MMTV integration site family, member 5A
  275. NEFL neurofilament, light polypeptide 68kDa
  276. ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
  277. NR3C2 nuclear receptor subfamily 3, group C, member 2
  278. DCN decorin
  279. EGR1 early growth response 1
  280. PRKCA protein kinase C, alpha
  281. GRN granulin
  282. PAK1 p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)
  283. GFAP glial fibrillary acidic protein
  284. CHRNA7 cholinergic receptor, nicotinic, alpha 7
  285. PTPN11 protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)
  286. APOB apolipoprotein B (including Ag(x) antigen)
  287. PPARA peroxisome proliferator-activated receptor alpha
  288. HADHA hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit
  289. F7 coagulation factor VII (serum prothrombin conversion accelerator)
  290. AVPR2 arginine vasopressin receptor 2 (nephrogenic diabetes insipidus)
  291. HLA-G HLA-G histocompatibility antigen, class I, G
  292. VAV1 vav 1 guanine nucleotide exchange factor
  293. C3 complement component 3
  294. TLR4 toll-like receptor 4
  295. BRCC3 BRCA1/BRCA2-containing complex, subunit 3
  296. ADRB3 adrenergic, beta-3-, receptor
  297. TNFRSF1A tumor necrosis factor receptor superfamily, member 1A
  298. TYR tyrosinase (oculocutaneous albinism IA)
  299. LRRK2 leucine-rich repeat kinase 2
  300. ERCC6 excision repair cross-complementing rodent repair deficiency, complementation group 6
  301. DBH dopamine beta-hydroxylase (dopamine beta-monooxygenase)
  302. SQSTM1 sequestosome 1
  303. ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide
  304. MAOA monoamine oxidase A
  305. BCR breakpoint cluster region
  306. HDAC1 histone deacetylase 1
  307. PECAM1 platelet/endothelial cell adhesion molecule (CD31 antigen)
  308. ABO ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
  309. GSR glutathione reductase
  310. GSK3B glycogen synthase kinase 3 beta
  311. ELN elastin (supravalvular aortic stenosis, Williams-Beuren syndrome)
  312. OXA1L oxidase (cytochrome c) assembly 1-like
  313. PTPRC protein tyrosine phosphatase, receptor type, C
  314. ALB albumin
  315. HNF1A HNF1 homeobox A
  316. S100A1 S100 calcium binding protein A1
  317. KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2
  318. MYH7 myosin, heavy chain 7, cardiac muscle, beta
  319. GALC galactosylceramidase
  320. SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1
  321. NOD2 nucleotide-binding oligomerization domain containing 2
  322. CD14 CD14 molecule
  323. TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box)
  324. ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide
  325. XRCC1 X-ray repair complementing defective repair in Chinese hamster cells 1
  326. ADORA1 adenosine A1 receptor
  327. FLT3 fms-related tyrosine kinase 3
  328. SHH sonic hedgehog homolog (Drosophila)
  329. DPP4 dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2)
  330. UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
  331. LAMP1 lysosomal-associated membrane protein 1
  332. GUSB glucuronidase, beta
  333. DST dystonin
  334. CAT catalase
  335. AIRE autoimmune regulator
  336. MSH6 mutS homolog 6 (E. coli)
  337. TOP1 topoisomerase (DNA) I
  338. TBP TATA box binding protein
  339. HMGB1 high-mobility group box 1
  340. MAPT microtubule-associated protein tau
  341. VHL von Hippel-Lindau tumor suppressor
  342. SHBG sex hormone-binding globulin
  343. ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
  344. IL8RB interleukin 8 receptor, beta
  345. CREB1 cAMP responsive element binding protein 1
  346. WTAP Wilms tumor 1 associated protein
  347. CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
  348. IFNG interferon, gamma
  349. CD59 CD59 molecule, complement regulatory protein
  350. AKR1A1 aldo-keto reductase family 1, member A1 (aldehyde reductase)
  351. PGR progesterone receptor
  352. ADORA2A adenosine A2a receptor
  353. CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1
  354. YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
  355. CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19
  356. ACTG1 actin, gamma 1
  357. AGTR1 angiotensin II receptor, type 1
  358. JAK1 Janus kinase 1 (a protein tyrosine kinase)
  359. CRP C-reactive protein, pentraxin-related
  360. BCHE butyrylcholinesterase
  361. ITGA2B integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
  362. CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1)
  363. ABCC8 ATP-binding cassette, sub-family C (CFTR/MRP), member 8
  364. HSP90B1 heat shock protein 90kDa beta (Grp94), member 1
  365. PON1 paraoxonase 1
  366. GALK1 galactokinase 1
  367. CASP7 caspase 7, apoptosis-related cysteine peptidase
  368. MME membrane metallo-endopeptidase
  369. GAL galanin prepropeptide
  370. CAV1 caveolin 1, caveolae protein, 22kDa
  371. THRA thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian)
  372. LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
  373. FGF1 fibroblast growth factor 1 (acidic)
  374. SPTB spectrin, beta, erythrocytic (includes spherocytosis, clinical type I)
  375. JUP junction plakoglobin
  376. HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10
  377. PARK7 Parkinson disease (autosomal recessive, early onset) 7
  378. IRS1 insulin receptor substrate 1
  379. NGFB nerve growth factor, beta polypeptide
  380. TGFBR2 transforming growth factor, beta receptor II (70/80kDa)
  381. IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
  382. CRYAB crystallin, alpha B
  383. SELL selectin L (lymphocyte adhesion molecule 1)
  384. IL10 interleukin 10
  385. AGER advanced glycosylation end product-specific receptor
  386. NCAM1 neural cell adhesion molecule 1
  387. IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
  388. MMP1 matrix metallopeptidase 1 (interstitial collagenase)
  389. ATR ataxia telangiectasia and Rad3 related
  390. SLC6A4 solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
  391. APOA1 apolipoprotein A-I
  392. SLC6A2 solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
  393. TXN thioredoxin
  394. RPS27A ribosomal protein S27a
  395. ALDH1A1 aldehyde dehydrogenase 1 family, member A1
  396. CEBPB CCAAT/enhancer binding protein (C/EBP), beta
  397. SMAD2 SMAD family member 2
  398. CLU clusterin
  399. GADD45A growth arrest and DNA-damage-inducible, alpha
  400. TH tyrosine hydroxylase
  401. NBN nibrin
  402. F13A1 coagulation factor XIII, A1 polypeptide
  403. POLG polymerase (DNA directed), gamma
  404. PICK1 protein interacting with PRKCA 1
  405. MAPK10 mitogen-activated protein kinase 10
  406. LTA lymphotoxin alpha (TNF superfamily, member 1)
  407. ADA adenosine deaminase
  408. NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
  409. IL1A interleukin 1, alpha
  410. HSPA4 heat shock 70kDa protein 4
  411. GAD2 glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
  412. CAMK2G calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma
  413. HDAC9 histone deacetylase 9
  414. ACACA acetyl-Coenzyme A carboxylase alpha
  415. OPRM1 opioid receptor, mu 1
  416. TLR2 toll-like receptor 2
  417. OGG1 8-oxoguanine DNA glycosylase
  418. ADRA2A adrenergic, alpha-2A-, receptor
  419. FADD Fas (TNFRSF6)-associated via death domain
  420. CCR2 chemokine (C-C motif) receptor 2
  421. COL2A1 collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital)
  422. RXRA retinoid X receptor, alpha
  423. ENO1 enolase 1, (alpha)
  424. SELP selectin P (granule membrane protein 140kDa, antigen CD62)
  425. ALS2 amyotrophic lateral sclerosis 2 (juvenile)
  426. KCNQ1 potassium voltage-gated channel, KQT-like subfamily, member 1
  427. PSEN2 presenilin 2 (Alzheimer disease 4)
  428. THRB thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)
  429. ANXA2 annexin A2
  430. NPY neuropeptide Y
  431. AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
  432. LRP1 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
  433. CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1
  434. CCL5 chemokine (C-C motif) ligand 5
  435. LCT lactase
  436. HLA-A major histocompatibility complex, class I, A
  437. BMP2 bone morphogenetic protein 2
  438. ATRX alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)
  439. CD40 CD40 molecule, TNF receptor superfamily member 5
  440. MEF2A myocyte enhancer factor 2A
  441. F2 coagulation factor II (thrombin)
  442. PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  443. FASN fatty acid synthase
  444. TGM2 transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)
  445. ARAF v-raf murine sarcoma 3611 viral oncogene homolog
  446. PARK2 Parkinson disease (autosomal recessive, juvenile) 2, parkin
  447. CETP cholesteryl ester transfer protein, plasma
  448. TGFBR1 transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa)
  449. PC pyruvate carboxylase
  450. KLF6 Kruppel-like factor 6
  451. IL12B interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)
  452. ATXN1 ataxin 1
  453. ACP1 acid phosphatase 1, soluble
  454. SELE selectin E (endothelial adhesion molecule 1)
  455. TF transferrin
  456. BCL6 B-cell CLL/lymphoma 6 (zinc finger protein 51)
  457. SCARB1 scavenger receptor class B, member 1
  458. ALOX5 arachidonate 5-lipoxygenase
  459. APAF1 apoptotic peptidase activating factor 1
  460. SLC1A2 solute carrier family 1 (glial high affinity glutamate transporter), member 2
  461. GPI glucose phosphate isomerase
  462. UBE3A ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome)
  463. TPP1 tripeptidyl peptidase I
  464. TIMP1 TIMP metallopeptidase inhibitor 1
  465. ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme)
  466. AURKA aurora kinase A
  467. CD36 CD36 molecule (thrombospondin receptor)
  468. NRG1 neuregulin 1
  469. FAP fibroblast activation protein, alpha
  470. TAZ tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome)
  471. BDKRB2 bradykinin receptor B2
  472. ASPA aspartoacylase (Canavan disease)
  473. P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7
  474. CDKN1C cyclin-dependent kinase inhibitor 1C (p57, Kip2)
  475. GH1 growth hormone 1
  476. SLC6A3 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
  477. ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3
  478. HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme A reductase
  479. PHB prohibitin
  480. IL18 interleukin 18 (interferon-gamma-inducing factor)
  481. DNAH8 dynein, axonemal, heavy chain 8
  482. RICTOR
  483. AHR aryl hydrocarbon receptor
  484. FSHR follicle stimulating hormone receptor
  485. ADSL adenylosuccinate lyase
  486. TNFRSF1B tumor necrosis factor receptor superfamily, member 1B
  487. MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase)
  488. HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
  489. ASL argininosuccinate lyase
  490. APOD apolipoprotein D
  491. TPMT thiopurine S-methyltransferase
  492. CRH corticotropin releasing hormone
  493. ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4
  494. PTPRF protein tyrosine phosphatase, receptor type, F
  495. HTR2A 5-hydroxytryptamine (serotonin) receptor 2A
  496. LAMA1 laminin, alpha 1
  497. HES1 hairy and enhancer of split 1, (Drosophila)
  498. APTX aprataxin
  499. HADHB hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit
  500. SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1